Table 3.
Gas chromatography, Capillary electrophoresis and Voltammetric techniques coupled with Hollow fiber based extraction techniques for determination of pharmaceutical drugs.
| Instrumental technique | Drug | Preconcentration/Separation method | SLM +/Carrier/FLM/Membrane | Real applications | LODa | EF/PF/EFb | LRc | Instrumental technique mode | Ref. |
|---|---|---|---|---|---|---|---|---|---|
| Gas chromatography | Cyproheptadine, ketotifen | EM-SPME | NPOE | Water, urine, plasma | 01–1.1 ng/mL | — | 0.3–200 and 0.5–750 ng/mL | GC-FID | [110] |
| Trimipramine, clomipramine | G-EME/DLLME | Agarose gel | Urine | 1.0–3.0 ng/L | 260–370 | 3.5–1000 ng/mL | GC-FID | [111] | |
| Clomipramine, imipramine | EME-EALLME | 2-ethylhexanol | Urine, wastewater | 0.15 ng/mL | 770.3 | 0.5–750 ng/mL | GC-FID | [112] | |
| Capillary electrophoresis | Nort [112]riptyline, papaverine, haloperidol | μEME | ENB | Urine, plasma | ≤0.15 mg/L | — | 1–20 mg/L | CE-UV | [113] |
| Nortriptyline, haloperidol, loperamide, ketoprofen, naproxen | EME | ENB | Urine | 0.075–1.5 μg/mL | — | 1–40 μg/mL | CE-DAD | [114] | |
| Imatinibmesylate | EME | NPOE + MWCNT/ZnO coated by 1-octyl-3-methylimidazolium bromide ionic liquid | Plasma | 6.24 ng/mL | 78 | 25–1500 ng/mL | CE-UV | [115] | |
| Nortriptyline, papaverine | μEME | 4-nitrocumene | Urine | ≤0.15 μg/mL | — | 0.5–10 μg/mL | CE-UV | [116] | |
| Amitriptyline, haloperidol, bupivacaine, propranolol | Pa-EME | NPOE | Plasma | — | — | — | CE-UV | [117] | |
| Methadone, methamphetamine, tramadol | EME | NPOE + MIL-110(Cr) | Urine, plasma | 0.30–0.91 μg/L | 132–190 | 1–1000 μg/L | CE-UV | [118] | |
| Tramadol, pseudoephedrine | EME | NPOE + span 80 | Urine | 2.10–4.50 μg/L | 160–188 | 5–2000 μg/L | CE-UV | [119] | |
| Capecitabine, 5-Fluorouracil | HF-SLPME | 1-octanol | Plasma | 6.4–9.3 ng/mL | — | 25–1000 ng/mL | CE-UV | [120] | |
| Tranylcypromine | S/EME | NPOE | Urine, water | 3.03–6.06 ng/mL | 166–203 | 10–1000 ng/mL | CE-UV | [121] | |
| Ibuprofen, naproxen, ketoprofen, diclofenac | μEME | 1-octanol | Urine, serum, wastewater | 4–20 ng/mL | 18–29.1 | 50–2500 ng/mL | CE-UV | [122] | |
| Nortriptyline, papaverine, haloperidol and loperamide | SLM extraction | ENB | Urine, plasma | 0.02–0.15 μg/mL | — | 0.5–30 μg/mL | CE-UV | [123] | |
| Ibuprofen, diclofenac, naproxen, ketoprofen, salicylic acid | On chip-EME | Undecanol + NPOE | Urine | 0.07–5 μg/mL | — | — | CE/HPLC-DA | [124] | |
| Voltammetry | Amlodipine | EME | NPOE | Whole blood | 0.05 ng/mL | 61 | 0.1–10 and 10–1000 ng/mL | FFSSWV | [125] |
| Diclofenec | EME | 1-octanol | Whole blood | 1 ng/mL | — | 5–1000 ng/mL | SFFTCCV | [126] | |
| Imatinib | HFSPME | — | Serum, urine | 7.39× 10−3 μmol/L | — | 0.010–200 μmol/L | DPV | [127] | |
| Estradiol valerate | EME | 1-octanol | Whole blood | 0.01 ng/mL | 2 | 0.1–1300 and 1300–10,000 ng/mL | FFTSWV | [128] | |
| Propylthiouracil | EME | Nitrobenzene + CuNPs | Urine | 0.02 μg/mL | 200 | 0.5–5 μg/mL | DPV | [129] | |
| Imipramine | EME | NPOE | Urine, whole blood | 0.001–0.01 ng/mL | 35–54 | 0.02–1000 and 0.2–1000 ng/mL | FFTSWV | [130] | |
| Vanillylmandelic acid | HFLPME | Butyl benzoate | Urine | 0.5 μmol/L | — | 0.5–100 μmol/L | DPV | [131] |
EME-EALLME: Electromembrane extraction and electro-assisted liquid-liquid microextraction, EM-SPME: Electromembrane surrounded solid phase microextraction, G-EME/DLLME: Gel-electromembrane exraction / dispersive liquid-liquid microextraction, Pa-EME: Parallel electromembrane extraction, ENB: 1-ethyl-2-nitrobenzene, MWCNTs: Multi-walled carbon nanotubes, MIL-110(Cr): Chromium terephthalate metal-organic framework, Span-80: Mono-(9Z)-9-octadecenoate, CuNPs: Copper nanoparticles, GC-FID: Gas chromatography with flame ionization detector,CE-UV: Capillary electrophoresis with UV detector, CE-DAD: Capillary electrophoresis with diode array detector, FFSSWV: Fast Fourier transform stripping square wave voltammetry, SFFTCCV: Stripping fast Fourier transform continuous cyclic voltammetry, DPV: Differential pulse voltammetry, FFTSWV: Fast Fourier transform square wave voltammetry.
Limit of detection.
Enrichment factor.
Linear range.